Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway.

[1]  Suhong Chen,et al.  Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review , 2023, Molecules.

[2]  H. Kan,et al.  Lung cancer as adverse health effect by indoor radon exposure in China from 2000 to 2020: A systematic review and meta-analysis. , 2022, Indoor air.

[3]  Dekai Zhang,et al.  Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy , 2022, Frontiers in Immunology.

[4]  Caicun Zhou,et al.  Non‐small cell lung cancer in China , 2022, Cancer communications.

[5]  X. Qiao,et al.  Chemical analysis of the Chinese herbal medicine licorice (Gan-Cao): An update review. , 2022, Journal of ethnopharmacology.

[6]  Hongbing Shen,et al.  Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese. , 2022, Cancer cell.

[7]  K. Kang,et al.  Anticolon Cancer Effect of Korean Red Ginseng via Autophagy- and Apoptosis-Mediated Cell Death , 2022, Nutrients.

[8]  L. Paz-Ares,et al.  Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer , 2022, Expert opinion on emerging drugs.

[9]  Jinhua Xu,et al.  Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer , 2022, Chemotherapy.

[10]  Jing Liu,et al.  Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation in vivo , 2022, Aging.

[11]  L. Meng,et al.  The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis , 2022, Investigational New Drugs.

[12]  Hongyu Zhang,et al.  Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer , 2022, Cancer Immunology, Immunotherapy.

[13]  Chang-Young Jang,et al.  Ginsenoside Rg1 suppresses cancer cell proliferation through perturbing mitotic progression , 2021, Journal of ginseng research.

[14]  S. Kim,et al.  Phytochemistry of ginsenosides: Recent advancements and emerging roles , 2021, Critical reviews in food science and nutrition.

[15]  B. Baradaran,et al.  PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Min Song,et al.  Danggui Buxue Decoction enhances the anticancer activity of gemcitabine and alleviates gemcitabine-induced Myelosuppression. , 2021, Journal of ethnopharmacology.

[17]  Ming Kong,et al.  Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer. , 2021, Food & function.

[18]  X. Ren,et al.  Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer , 2021, Cancer biology & medicine.

[19]  Wei Zhang,et al.  Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury. , 2020, Journal of ethnopharmacology.

[20]  Feng Zhu,et al.  FGD5-AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR-142-5p/PD-L1 axis , 2020, International journal of molecular medicine.

[21]  A. Sica,et al.  Regulation of PD-L1 Expression by NF-κB in Cancer , 2020, Frontiers in Immunology.

[22]  A. Pourbagheri-Sigaroodi,et al.  The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target? , 2020, Journal of cellular physiology.

[23]  Jingjing Li,et al.  Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[24]  J. Miao,et al.  Recent Advances in the Tissue Culture of American Ginseng (Panax quinquefolius) , 2020, Chemistry & biodiversity.

[25]  Li Yang,et al.  Advances on hormone-like activity of Panax ginseng and ginsenosides. , 2020, Chinese journal of natural medicines.

[26]  Hongyu Liu,et al.  Advances in immune neoadjuvant/adjuvant therapy‐related adverse events of non‐small cell lung cancer , 2020, Asia-Pacific journal of clinical oncology.

[27]  J. Bauml,et al.  First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches , 2020, Journal of the advanced practitioner in oncology.

[28]  N. Aguilera,et al.  T-cell lymphoproliferative processes in the spleen. , 2019, Seminars in diagnostic pathology.

[29]  Daidi Fan,et al.  Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. , 2019, Food & function.

[30]  B. Majumder,et al.  Ferulic acid enhances the radiation sensitivity of lung and liver carcinoma cells by collapsing redox homeostasis: mechanistic involvement of Akt/p38 MAPK signalling pathway , 2019, Free radical research.

[31]  I. Song,et al.  Interactions of ginseng with therapeutic drugs , 2019, Archives of Pharmacal Research.

[32]  Liangzhi Li,et al.  The antitumor effect of hinesol, extract from Atractylodes lancea (Thunb.) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF‐κB pathway in non–small cell lung cancer cell lines A549 and NCI‐H1299 , 2019, Journal of cellular biochemistry.

[33]  L. Qin,et al.  The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review. , 2018, Journal of ethnopharmacology.

[34]  T. Schumacher,et al.  Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.

[35]  Dawei Yuan,et al.  Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level , 2018, BioMed research international.

[36]  Q-F Yue,et al.  Liquiritin (LT) exhibits suppressive effects against the growth of human cervical cancer cells through activating Caspase-3 in vitro and xenograft mice in vivo. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[37]  Toshiaki Suzuki,et al.  Effect of ninjin’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice , 2017, Journal of Natural Medicines.

[38]  G. Hortobagyi,et al.  Deubiquitination and Stabilization of PD-L1 by CSN5. , 2016, Cancer cell.

[39]  Jingsheng Du,et al.  Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway , 2016, Drug design, development and therapy.

[40]  Jin-jian Lu,et al.  A Systematic Review of the Anticancer Properties of Compounds Isolated from Licorice (Gancao) , 2015, Planta Medica.

[41]  Jing-Gung Chung,et al.  Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma In Vitro and In Vivo. , 2020, The American journal of Chinese medicine.

[42]  Yanling Zhou,et al.  Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells. , 2014, Oncology reports.